Postsurgical Pyoderma Gangrenosum After Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Case Report

JBJS Case Connect. 2023 Nov 28;13(4). doi: 10.2106/JBJS.CC.23.00087. eCollection 2023 Oct 1.

Abstract

Case: A 61-year-old woman with lower back and radicular leg pain underwent minimally invasive spinal fusion at L5-S1. By postoperative day 6, she exhibited erythema, wound dehiscence, and necrotic changes. Although a necrotizing infection was initially suspected, multiple debridements and antibiotic therapy failed to improve her condition. The patient was eventually diagnosed with pyoderma gangrenosum (PG) and was managed with immunosuppressants and extended wound care.

Conclusion: PG is a rare dermatosis that is often misdiagnosed, leading to inappropriate treatment, debridements, and additional complications. Prompt identification and multidisciplinary collaboration are key to preventing unnecessary interventions and achieving the best outcomes.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Immunosuppressive Agents
  • Middle Aged
  • Pyoderma Gangrenosum* / surgery
  • Spinal Fusion* / adverse effects

Substances

  • Immunosuppressive Agents